APEX-STROKE EAGLE Domain (EAGLE)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 878 participants.
Also called NCT07790354
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 878 participants
- Registry
-
NCT07790354
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07790354. Randomized; single masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- APEX-STROKE EAGLE Domain (EAGLE)
- Acronym
- EAGLE
- Condition
- Stroke
- Condition
- Intracerebra Hemorrhage
- Intervention (Other)
- Early surgical bundle
- Intervention (Other)
- Guideline-Based Standard Care
- Lead sponsor
- Fudan University
- Collaborator
- Huashan Hospital
- Collaborator
- First Affiliated Hospital of Fujian Medical University
Record details
- Record id
cardio:ct-nct07790354- Content hash
9ece3bc35190043be45557bb1f34ec40e0bbb6e8c3b70e9541b9a0d7a31442fe